Wells Fargo sees 2% quarterly drop in US Medicaid enrollment

Total Medicaid enrollment is tracking toward a 2% quarterly decline in Q1, with expansion enrollment down ~1% QoQ and monthly drops of 0.8% (Jan), 0.7% (Feb) and 0.5% (Mar). California is tracking toward a ~3% quarterly decline versus a 1.3% drop in Q4 2025; Wells Fargo attributes deterioration to stricter eligibility verification ahead of OBBBA changes and rising acuity. Wells Fargo notes the Q1 expansion decline of 1% is below the 2025 quarterly average of 1.5%, and an Urban Institute study projects potential enrollment losses of 4.9m–10.1m under work requirements plus a six‑month redeterminations process.

Analysis

The mechanics of verification-driven disenrollment produce a twin shock: elevated per-enrollee cost trends for payers and acute margin pressure for safety-net providers that lose low-acuity members. Because capitation and state payment adjustments typically lag real-time case-mix shifts, expect a multi-quarter window where managed-care operating metrics (medical-loss ratios, reserve builds) diverge from headline enrollment declines.

States will face a policy arithmetic choice: accept higher short-run per-person costs or raise rates/retroactive payments to stabilize access and avoid hospital strain. That dynamic increases political tail risk into the next budget cycle and creates predictable timing for rate filings, legislative interventions, and CMS guidance — each is a discrete catalyst that can reprice the sector quickly.

Second-order beneficiaries are firms that sell eligibility/renewal automation and call-center services, along with specialty providers that treat high-acuity populations (behavioral health, complex chronic care, infusion/infusions), who will see demand concentration even as overall headcount falls. Conversely, narrow-network pure-play Medicaid insurers and community hospitals are exposed to both administrative churn and potential reimbursement squeezes if states move to preserve budgets by tightening rates or delaying payments.

Key Decisions for Investors

• Pair trade (6–12 months): Long UNH / Short MOH — UNH’s diversified commercial and Medicare franchises provide ballast against Medicaid idiosyncrasies while MOH’s concentrated Medicaid exposure makes it more levered to acuity and redetermination execution risk. Target asymmetric payoff: 1.5–2x upside on UNH outperformance vs MOH; use 10% notional each side to limit basis risk.
• Short pure-play Medicaid MCOs (e.g., MOH) via outright equity or buy-to-open 6–9 month puts — thesis: near-term reserve and margin shock from case-mix plus political uncertainty. Position size: sized to 3–5% portfolio risk; hedge with broad healthcare basket to limit systemic beta.
• Long Medicaid eligibility/outsourcing vendors (select names in government services/IT) with a 9–18 month horizon — increased state outsourcing and one-time implementation work is a durable revenue source. Risk: state budget cuts; target 15–25% upside if several medium-sized state contracts are awarded.
• Event-driven alert: Monitor state rate filings and upcoming CMS rulemaking windows over the next 3–9 months. Use these as entry/exit triggers — if a major state signals emergency rate relief, reduce shorts by 30–50% within 48 hours to lock gains.